Acquisition History / Duomed Belgium NV (Palex Healthcare Group) / Launch Diagnostics Holdings Limited
Duomed Belgium NV (Palex Healthcare Group) Acquires Launch Diagnostics Holdings Limited
Announced March 7, 2025 — $17.4M
What happened
Launch Diagnostics is Avacta's UK-based distributor of in-vitro diagnostics products, with £17.9M revenue in 2023. Avacta sold it for £12.9M in cash to Duomed Belgium, part of Spain's Palex Healthcare Group, to fund its therapeutics work.
- Target
- Launch Diagnostics Holdings Limited
- Announced
- March 7, 2025
- Price
- $17.4M
- Industry
- Diagnostics distribution
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Duomed Belgium NV (Palex Healthcare Group) acquire Launch Diagnostics Holdings Limited?
Duomed Belgium NV (Palex Healthcare Group) acquired Launch Diagnostics Holdings Limited on March 7, 2025. This was Duomed Belgium NV (Palex Healthcare Group)'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Duomed Belgium NV (Palex Healthcare Group) pay for Launch Diagnostics Holdings Limited?
Duomed Belgium NV (Palex Healthcare Group) paid $17.4M for Launch Diagnostics Holdings Limited.
What does Launch Diagnostics Holdings Limited do?
Launch Diagnostics is Avacta's UK-based distributor of in-vitro diagnostics products, with £17.9M revenue in 2023. Avacta sold it for £12.9M in cash to Duomed Belgium, part of Spain's Palex Healthcare Group, to fund its therapeutics work.
What other Diagnostics distribution companies has Duomed Belgium NV (Palex Healthcare Group) acquired?
Launch Diagnostics Holdings Limited is Duomed Belgium NV (Palex Healthcare Group)'s only publicly tracked acquisition in Diagnostics distribution so far.